Verrica Pharmaceuticals, Inc. (VRCA)
7.26
-0.35
(-4.60%)
USD |
NASDAQ |
Jan 16, 16:00
7.40
+0.14
(+1.93%)
Pre-Market: 20:00
Verrica Pharmaceuticals Profit Margin (Quarterly): -1.91% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
| Oragenics, Inc. | -- |
| NanoViricides, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -62.02% |
| Return on Invested Capital | -115.0% |
| Gross Profit Margin (Quarterly) | 92.27% |
| Operating Margin (Quarterly) | 11.34% |
| Return on Net Operating Assets | -233.1% |